These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [New techniques for optimization of thiopurine therapy in leukemia and transplantation]. Loennechen T, Lysaa RA, Giverhaug T, Sylte I, Mathiesen LE, Aarbakke J. Tidsskr Nor Laegeforen; 2002 Apr 30; 122(11):1107-10. PubMed ID: 12043054 [Abstract] [Full Text] [Related]
5. The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia. Tumer TB, Ulusoy G, Adali O, Sahin G, Gozdasoglu S, Arinç E. Am J Hematol; 2007 Oct 30; 82(10):906-10. PubMed ID: 17617792 [Abstract] [Full Text] [Related]
7. Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia. Albayrak M, Konyssova U, Kaya Z, Gursel T, Guntekin S, Percin EF, Kocak U. Cancer Chemother Pharmacol; 2011 Nov 30; 68(5):1155-9. PubMed ID: 21400026 [Abstract] [Full Text] [Related]
12. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis. Peregud-Pogorzelski J, Tetera-Rudnicka E, Kurzawski M, Brodkiewicz A, Adrianowska N, Mlynarski W, Januszkiewicz D, Drozdzik M. Pediatr Blood Cancer; 2011 Oct 30; 57(4):578-82. PubMed ID: 21319286 [Abstract] [Full Text] [Related]
16. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond. Karas-Kuzelicki N, Mlinaric-Rascan I. Pharmacogenomics; 2009 Aug 30; 10(8):1309-22. PubMed ID: 19663675 [Abstract] [Full Text] [Related]